Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Florence Oral Suspension in Adults With Eosinophilic Esophagitis
NCT02873468Phase 2Recruiting
- Sponsor
- EMS
- Start
- Apr 2021
- Primary completion
- Jul 2025
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of florence in eosinophilic esophagitis (EoE) (4 arms), sponsored by EMS. Primary endpoint: Proportion of participants presenting a histological response at 100 days. Started Apr 2021; status: recruiting.
02
Drugs
florence
03
Conditions
eosinophilic esophagitis (EoE)
Beyond the preview
Go deeper on NCT02873468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02873468.